These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9672461)

  • 21. Herpes Labialis: An Update.
    Leung AKC; Barankin B
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options for herpes labialis, I: Oral agents.
    Elish D; Singh F; Weinberg JM
    Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
    Strand A; Böttiger D; Gever LN; Wheeler W
    Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for short-course therapies in herpes genitalis and herpes labialis.
    Corey L; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():4A. PubMed ID: 17877885
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.
    Raborn GW; McGaw WT; Grace M; Tyrrell LD; Samuels SM
    J Am Dent Assoc; 1987 Jul; 115(1):38-42. PubMed ID: 3301980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. What are the best treatments for herpes labialis?
    Chon T; Nguyen L; Elliott TC
    J Fam Pract; 2007 Jul; 56(7):576-8. PubMed ID: 17605952
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
    Mira JA; López-Cortés LF; Merino D; Arizcorreta-Yarza A; Rivero A; Collado A; Ríos-Villegas MJ; González-Serrano M; Torres-Tortoso M; Macías J; Valera-Bestard B; Fernández-Fuertes E; Girón-González JA; Lozano F; Pineda JA;
    Antivir Ther; 2007; 12(8):1225-35. PubMed ID: 18240862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.
    Gilbert SC
    J Drugs Dermatol; 2007 Apr; 6(4):400-5. PubMed ID: 17668537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of herpes simplex labialis.
    Lancet; 1990 Jun; 335(8704):1501-2. PubMed ID: 1972438
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of recurrent herpes labialis.
    Sarnoff DS
    J Drugs Dermatol; 2014 Sep; 13(9):1016-8. PubMed ID: 25226000
    [No Abstract]   [Full Text] [Related]  

  • 33. Allergic contact cheilitis from a lipstick misdiagnosed as herpes labialis: Subsequent worsening due to Zovirax contact allergy.
    Ozkaya E; Topkarci Z; Ozarmağan G
    Australas J Dermatol; 2007 Aug; 48(3):190-2. PubMed ID: 17680974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare case of acyclovir-induced thrombocytopenia.
    Kamboj J; Wu F; Kamboj R; Suzue K; Khosla P
    Am J Ther; 2014; 21(5):e159-62. PubMed ID: 23344109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review.
    Hong X; Wang X; Wang Z
    BMC Pharmacol Toxicol; 2017 Mar; 18(1):12. PubMed ID: 28264696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
    Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
    J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutropenia associated with oral acyclovir and multiple antibacterial agents in a patient with acquired immunodeficiency syndrome.
    McPherson ML; Plaisance KI
    Clin Pharm; 1988 May; 7(5):398-401. PubMed ID: 3383546
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasculitic mononeuritis multiplex induced by valacyclovir.
    Pary LF; Henszel A; Kelkar P
    Neurology; 2004 May; 62(10):1906-7. PubMed ID: 15159513
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
    Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P;
    J Drugs Dermatol; 2014 Jul; 13(7):791-8. PubMed ID: 25007361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acyclovir for prevention of recurrent Herpes labialis?].
    Färber I
    Med Monatsschr Pharm; 2008 Jun; 31(6):226. PubMed ID: 18661914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.